The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines

References

• Arnold, J., Alving, A. S. & Clayman, C. B. (1961). Induced primaquine resistance in vivax malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 55, 345–350.
   PubMedGoogle Scholar
• Baird, J. K., Basri, H., Subianto, B., Fryauff, D. J., McElroy, P. D., Leksana, B., Richie, T. L., Masbar, S., Wignall, F. S. & Hoffman, S. L. (1995a). Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. Journal of Infectious Diseases, 171, 1678–1682.
   PubMed Web of Science ®Google Scholar
• Baird, J. K., Fryauff, D. J., Basri, H., Bangs, M. J., Subianto, B., Wiady, I., Purnomo, Leksana, B., Masbar, S., Richie, T. L., Jones, T. R., Tjitra, E., Wignall, S.F. & Hoffman, S. L. (1995b). Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. American Journal of Tropical Medicine and Hygiene, 52, 479–484.
   Google Scholar
• Basco, L. K., Bickii, J. & Ringwald, P. (1999). In vitro activity of primaquine against the asexual blood stages of Plasmodium falciparum. Annals of Tropical Medicine and Parasitology, 93, 179–182.
   PubMed Web of Science ®Google Scholar
• Carlton, J. M. R., Fidock, D. A., Djimde, A., Plowe, C. V. & Wellems, T. E. (2001). Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum. Current Opinions in Microbiology, 4, 415–420.
   PubMed Web of Science ®Google Scholar
• Carson, P. E. (1984). 8-Aminoquinolines. In Anti-malarial Drugs, Vol. 2, eds Peters, W. & Richards, W. H. G. pp. 83-121. Berlin: Springer Verlag.
   Google Scholar
• Coquelin, F., Biarnais, T., Deharo, E., Peters, W., Chabaud, A. & Landau, I. (1997). Modifications in the rhythm of schizogony in Plasmodium chabaudi associated with the selection of chloroquine resist-ance. Parasitology Research, 83, 504–509.
   PubMed Web of Science ®Google Scholar
• Desjardins, R. E., Doberstyn, E. B. & Wernsdorfer, W. H. (1988). The treatment and prophylaxis of malaria. In Malaria: Principles and Practice of Malariology, Vol. 1, eds Wernsdorfer, W. H. & McGregor, I, pp. 827-864. London: Churchill Livingstone.
   Google Scholar
• Fryauff, D. J., Baird, J. K., Basri, H., Sumawinata, I., Purnomo, Richei, T. L., Ohrt, C. K., Mouzin, E., Church, C. J., Richards, A. L., Subianto, B., Sanjaja, B., Wignall, F.S. & Hoffman, S. L.(1995). Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet, 346, 1190–1193.
   Google Scholar
• Garfield, R. M. & Vermund, S. H. (1986). Health education and community participation in mass drug administration for malaria in Nicaragua. Social Science and Medicine, 22, 869–877.
   PubMed Web of Science ®Google Scholar
• Haworth, J. (1988). The global distribution of malaria and the present control effort. In Malaria: Principles and Practice of Malariology, Vol. 2, eds Wernsdorfer, W. H. & McGregor, I, pp. 1379-1420. London: Churchill Livingstone.
   Google Scholar
• Lell, B., Faucher, J.-F., Missinou, M. A., Bormann, S., Dangelmaiere, O., Horton, J. & Kremsner, P. G.(2000). Malaria chemoprophylaxis with tafenoquine; a randomised study. Lancet, 355, 2041–2045.
   Google Scholar
• Merkli, B. & Peters, W. (1976). A comparison of two different methods for the selection of primaquine resistance in Plasmodium berghei berghei. Annals of Tropical Medicine and Parasitology, 70, 473–474.
   PubMed Web of Science ®Google Scholar
• Peters, W. (1965). Mepacrine- and primaquine-resistant strains of Plasmodium berghei, Vincke and Lips, 1948. Nature, 203, 693–694.
   Web of Science ®Google Scholar
• Peters, W. (1968). The chemotherapy of rodent malaria. V. Dynamics of drug resistance, part I: methods for studying the acquisition and loss of resistance to chloroquine by Plasmodium berghei. Annals of Tropical Medicine and Parasitology, 62, 277–287.
   PubMed Web of Science ®Google Scholar
• Peters, W. (1987). Chemotherapy and Drug Resistance in Malaria, 2nd Edn. London: Academic Press.
   Google Scholar
• Peters, W. (1999a). A new antimalarial for a new millennium? — The evolution of tafenoquine (an 8-aminoquinoline) from methylene blue. Journal of the Royal Society of Medicine, 92, 345–352.
   PubMed Web of Science ®Google Scholar
• Peters, W. (1999b). The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of resistance, part 1: which model is appro-priate? Annals of Tropical Medicine and Parasitology, 93, 569–587.
   PubMed Web of Science ®Google Scholar
• Peters, W., Portus, J. & Robinson, B. L. (1977). The chemotherapy of rodent malaria. XXVIII. The development of resistance to mefloquine (WR, 142,490). Annals of Tropical Medicine and Parasitology, 71, 419–427.
   PubMed Web of Science ®Google Scholar
• Peters, W., Robinson, B. L. & Milhous, W. K. (1993). The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605. Annals of Tropical Medicine and Parasitology, 87, 547–552.
   PubMed Web of Science ®Google Scholar
• Pukrittayakamee, S., Vanijanonta, S., Chantra, A., Clemens, R. & White, N. J. (1994). Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. Journal of Infectious Diseases, 169, 932–935.
   PubMed Web of Science ®Google Scholar
• Puri, S. K. & Dutta, G. P. (1989). Delay in emergence of mefloquine resistance in Plasmodium berghei by use of drug combinations. Acta Tropica, 46, 209-212. Shanks, G. D., Kain, K. C. & Keystone, J. S. (2001a). Malaria chemoprophylaxis in the age of drug resist-ance. II. Drugs that may be available in the future. Clinical Infectious Diseases, 33, 381–385.
   Google Scholar
• Shanks, G. D., Oloo, A. J., Aleman, G. M., Ohrt, C., Klotz, F. W., Braitman, D., Horton, J. & Brueckner, R. (2001b). A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clinical Infectious Diseases, 33, 1968–1974.
   PubMed Web of Science ®Google Scholar
• Soto, J., Toledo, J., Rodriguez, M., Sanchez, J., Herrera, R., Padilla, J. & Berman, J. (1998). Primaquine prophylaxis against malaria in non-immune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 129, 241–244.
   PubMed Web of Science ®Google Scholar
• Soto, J., Toledo, J., Rodriguez, M., Sanchez, J., Hererra, R., Padilla, J. & Berman, J. (1999). Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers. Clinical Infectious Diseases, 29, 199–201.
   PubMed Web of Science ®Google Scholar
• Weiss, W. R., Oloo, A. J., Johnson, A., Koech, D. & Hoffman, S. L. (1995). Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloro-quine plus proguanil. Journal of Infectious Diseases, 171, 1569–1575.
   PubMed Web of Science ®Google Scholar
• White, N. J. (1998). Preventing antimalarial drug resist-ance through combinations. Drug Resistance Updates, 1, 3–9.
   PubMed Web of Science ®Google Scholar
• Wilairatana, P., Silachamroon, U., Krudsood, S., Singhasivanon, P., Treeprasertsuk, S., Bussaratid, V., Phumratanaprapin, W., Srivilirit, S. & Looareesuwan, S. (1999). Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 61, 973–977.
   PubMed Web of Science ®Google Scholar
• World Health Organization (1984). Advances in Malaria Chemotherapy. Report of a WHO Scientific Group. Technical Report Series No. 711. Geneva: WHO. World Health Organization (2002). Survival Benefit of Giving Intermittent Malaria Treatment as a Component of the Expanded Programme of Immunization (EPI) Schedule in Africa. Call for Letters of Interest. Geneva: WHO.
   Google Scholar